Investigational insulin secretagogues for type 2 diabetes.
about
Therapeutic application of GPR119 ligands in metabolic disorders.FFA4/GPR120: Pharmacology and Therapeutic Opportunities.Influence of Flavonoids on Mechanism of Modulation of Insulin Secretion.Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes.Stevia Nonsweetener Fraction Displays an Insulinotropic Effect Involving Neurotransmission in Pancreatic Islets.
P2860
Investigational insulin secretagogues for type 2 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Investigational insulin secretagogues for type 2 diabetes.
@en
type
label
Investigational insulin secretagogues for type 2 diabetes.
@en
prefLabel
Investigational insulin secretagogues for type 2 diabetes.
@en
P2860
P1476
Investigational insulin secretagogues for type 2 diabetes.
@en
P2093
André J Scheen
P2860
P304
P356
10.1517/13543784.2016.1152260
P407
P577
2016-02-16T00:00:00Z